Motor Activated Auricular Vagus Nerve Stimulation as a Potential Neuromodulation Approach for Post-Stroke Motor Rehabilitation: A Pilot Study.

MAAVNS motor activated auricular vagus nerve stimulation motor rehabilitation stroke tVNS taVNS transcutaneous auricular vagus nerve stimulation

Journal

Neurorehabilitation and neural repair
ISSN: 1552-6844
Titre abrégé: Neurorehabil Neural Repair
Pays: United States
ID NLM: 100892086

Informations de publication

Date de publication:
Jun 2023
Historique:
medline: 3 7 2023
pubmed: 20 5 2023
entrez: 20 5 2023
Statut: ppublish

Résumé

Implanted vagus nerve stimulation (VNS), when synchronized with post-stroke motor rehabilitation improves conventional motor rehabilitation training. A non-invasive VNS method known as transcutaneous auricular vagus nerves stimulation (taVNS) has emerged, which may mimic the effects of implanted VNS. To determine whether taVNS paired with motor rehabilitation improves post-stroke motor function, and whether synchronization with movement and amount of stimulation is critical to outcomes. We developed a closed-loop taVNS system for motor rehabilitation called motor activated auricular vagus nerve stimulation (MAAVNS) and conducted a randomized, double-blind, pilot trial investigating the use of MAAVNS to improve upper limb function in 20 stroke survivors. Participants attended 12 rehabilitation sessions over 4-weeks, and were assigned to a group that received either MAAVNS or active unpaired taVNS concurrently with task-specific training. Motor assessments were conducted at baseline, and weekly during rehabilitation training. Stimulation pulses were counted for both groups. A total of 16 individuals completed the trial, and both MAAVNS (n = 9) and unpaired taVNS (n = 7) demonstrated improved Fugl-Meyer Assessment upper extremity scores (Mean ± SEM, MAAVNS: 5.00 ± 1.02, unpaired taVNS: 3.14 ± 0.63). MAAVNS demonstrated greater effect size (Cohen's This trial suggests stimulation timing likely matters, and that pairing taVNS with movements may be superior to an unpaired approach. Additionally, MAAVNS effect size is comparable to that of the implanted VNS approach.

Sections du résumé

BACKGROUND BACKGROUND
Implanted vagus nerve stimulation (VNS), when synchronized with post-stroke motor rehabilitation improves conventional motor rehabilitation training. A non-invasive VNS method known as transcutaneous auricular vagus nerves stimulation (taVNS) has emerged, which may mimic the effects of implanted VNS.
OBJECTIVE OBJECTIVE
To determine whether taVNS paired with motor rehabilitation improves post-stroke motor function, and whether synchronization with movement and amount of stimulation is critical to outcomes.
METHODS METHODS
We developed a closed-loop taVNS system for motor rehabilitation called motor activated auricular vagus nerve stimulation (MAAVNS) and conducted a randomized, double-blind, pilot trial investigating the use of MAAVNS to improve upper limb function in 20 stroke survivors. Participants attended 12 rehabilitation sessions over 4-weeks, and were assigned to a group that received either MAAVNS or active unpaired taVNS concurrently with task-specific training. Motor assessments were conducted at baseline, and weekly during rehabilitation training. Stimulation pulses were counted for both groups.
RESULTS RESULTS
A total of 16 individuals completed the trial, and both MAAVNS (n = 9) and unpaired taVNS (n = 7) demonstrated improved Fugl-Meyer Assessment upper extremity scores (Mean ± SEM, MAAVNS: 5.00 ± 1.02, unpaired taVNS: 3.14 ± 0.63). MAAVNS demonstrated greater effect size (Cohen's
CONCLUSION CONCLUSIONS
This trial suggests stimulation timing likely matters, and that pairing taVNS with movements may be superior to an unpaired approach. Additionally, MAAVNS effect size is comparable to that of the implanted VNS approach.

Identifiants

pubmed: 37209010
doi: 10.1177/15459683231173357
pmc: PMC10363288
mid: NIHMS1893293
doi:

Types de publication

Randomized Controlled Trial Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

374-383

Subventions

Organisme : RRD VA
ID : IK6 RX003075
Pays : United States
Organisme : NIGMS NIH HHS
ID : P20 GM109040
Pays : United States
Organisme : NIDA NIH HHS
ID : P50 DA046373
Pays : United States

Références

J Psychiatr Res. 2002 Jul-Aug;36(4):219-27
pubmed: 12191626
Exp Neurol. 1989 May;104(2):125-32
pubmed: 2707361
Childs Nerv Syst. 2000 Feb;16(2):101-2
pubmed: 10663816
Stroke. 2016 Jan;47(1):143-50
pubmed: 26645257
Brain Stimul. 2015 May-Jun;8(3):624-36
pubmed: 25573069
Neurorehabil Neural Repair. 2009 Sep;23(7):641-56
pubmed: 19531606
Brain Stimul. 2018 Jul - Aug;11(4):947-948
pubmed: 29895444
Scand J Rehabil Med. 1975;7(1):13-31
pubmed: 1135616
Neurorehabil Neural Repair. 2014 Sep;28(7):698-706
pubmed: 24553102
Exp Brain Res. 2003 Feb;148(4):504-8
pubmed: 12582834
Cereb Cortex. 2012 Oct;22(10):2365-74
pubmed: 22079923
Arch Phys Med Rehabil. 2009 Oct;90(10):1692-8
pubmed: 19801058
J Vis Exp. 2019 Jan 7;(143):
pubmed: 30663712
Neuroreport. 2014 Jun 18;25(9):676-82
pubmed: 24818637
Stroke. 2018 Nov;49(11):2789-2792
pubmed: 30355189
Exp Neurol. 2020 May;327:113220
pubmed: 32027928
Lancet. 2021 Apr 24;397(10284):1545-1553
pubmed: 33894832
Cereb Cortex. 2006 Aug;16(8):1106-15
pubmed: 16221926
Front Neurol. 2018 Nov 07;9:923
pubmed: 30464754
J Stroke Cerebrovasc Dis. 2018 Jul;27(7):1998-2005
pubmed: 29580658
Circulation. 2012 Jan 3;125(1):e2-e220
pubmed: 22179539
Neurorehabil Neural Repair. 2010 Sep;24(7):620-35
pubmed: 20424192
Neural Plast. 2020 Aug 1;2020:8841752
pubmed: 32802039
Occup Ther Int. 2009;16(3-4):175-89
pubmed: 19504501
Front Hum Neurosci. 2021 Mar 23;14:568051
pubmed: 33854421
Prog Brain Res. 2013;207:275-99
pubmed: 24309259
Exp Neurol. 2012 Jan;233(1):342-9
pubmed: 22079155
Neuropsychopharmacology. 2007 Aug;32(8):1649-60
pubmed: 17203016
Epilepsia. 1998 Jul;39(7):709-14
pubmed: 9670898
Ann Neurol. 2016 Sep;80(3):342-54
pubmed: 27447365
Lancet Neurol. 2004 Sep;3(9):528-36
pubmed: 15324721
NeuroRx. 2006 Oct;3(4):474-81
pubmed: 17012061
Am J Occup Ther. 2014 Jul-Aug;68(4):444-53
pubmed: 25005508
Arch Phys Med Rehabil. 2007 Jun;88(6):715-23
pubmed: 17532892
Neuromodulation. 2017 Apr;20(3):290-300
pubmed: 27898202
Arch Phys Med Rehabil. 2016 Nov;97(11):1863-1871
pubmed: 27117385
Biomed Tech (Berl). 2008 Jun;53(3):104-11
pubmed: 18601618
Neuromodulation. 2022 Apr;25(3):309-315
pubmed: 35396067
Circulation. 2022 Feb 22;145(8):e153-e639
pubmed: 35078371
Neurobiol Dis. 2013 Dec;60:80-8
pubmed: 23954448
Arch Phys Med Rehabil. 1993 Apr;74(4):347-54
pubmed: 8466415
Neurorehabil Neural Repair. 2013 Sep;27(7):602-12
pubmed: 23549521
Front Neurosci. 2021 Jul 13;15:709436
pubmed: 34326720
Brain Stimul. 2018 May - Jun;11(3):492-500
pubmed: 29361441
Brain Stimul. 2020 May - Jun;13(3):800-803
pubmed: 32289710
J Neural Transm (Vienna). 2007;114(11):1485-93
pubmed: 17564758

Auteurs

Bashar W Badran (BW)

Department of Psychiatry and Behavioral Sciences, Neuro-X Lab, Medical University of South Carolina, Charleston, SC, USA.
Deparment of Neuroscience, Medical University of South Carolina, Charleston, SC, USA.

Xiaolong Peng (X)

Department of Psychiatry and Behavioral Sciences, Neuro-X Lab, Medical University of South Carolina, Charleston, SC, USA.
Deparment of Neuroscience, Medical University of South Carolina, Charleston, SC, USA.

Brenna Baker-Vogel (B)

Department of Psychiatry and Behavioral Sciences, Neuro-X Lab, Medical University of South Carolina, Charleston, SC, USA.

Scott Hutchison (S)

Deparment of Neuroscience, Medical University of South Carolina, Charleston, SC, USA.

Patricia Finetto (P)

Department of Psychiatry and Behavioral Sciences, Neuro-X Lab, Medical University of South Carolina, Charleston, SC, USA.

Kelly Rishe (K)

Department of Health Sciences and Research, Medical University of South Carolina, Charleston, SC, USA.
Center for Neurotechnology and Neurorecovery, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
VA RR&D Center for Neurorestoration and Neurotechnology, Rehabilitation R&D Service, Department of VA Medical Center, Providence, RI, USA.

Andrew Fortune (A)

Deparment of Neuroscience, Medical University of South Carolina, Charleston, SC, USA.

Ellen Kitchens (E)

Department of Psychiatry and Behavioral Sciences, Neuro-X Lab, Medical University of South Carolina, Charleston, SC, USA.

Georgia H O'Leary (GH)

Department of Psychiatry and Behavioral Sciences, Neuro-X Lab, Medical University of South Carolina, Charleston, SC, USA.

Abigail Short (A)

Department of Psychiatry and Behavioral Sciences, Neuro-X Lab, Medical University of South Carolina, Charleston, SC, USA.

Christian Finetto (C)

Deparment of Neuroscience, Medical University of South Carolina, Charleston, SC, USA.

Michelle L Woodbury (ML)

Department of Health Sciences and Research, Medical University of South Carolina, Charleston, SC, USA.

Steve Kautz (S)

Department of Health Sciences and Research, Medical University of South Carolina, Charleston, SC, USA.
Ralph H Johnson VA Health Care System, Charleston, SC, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH